A tiny molecule discovered by Cedars-Sinai Heart Institute investigators — and fittingly named the “banana protein” — might hold the key to predicting heart failure.
News & Notes
New research led by the Cedars-Sinai Diabetes and Obesity Research Institute shows the prevalence of obesity among men residing at higher elevations is less than in those living in lower elevations.
An investigational stem cell therapy derived from patients’ own bone marrow significantly improved outcomes in people with severe heart failure, according to a study from the Cedars-Sinai Heart Institute.
In a landmark study, Cedars-Sinai researchers showed that a combination of adult stem cells and a specific bone-building hormone may significantly speed up the rate at which fractures caused by osteoporosis will mend.
Inflammation is at the root of many diseases, and humans are not the only ones fighting it. Bacteria also face many of the same challenges as patients with inflammatory diseases such as diabetes, rheumatoid arthritis, and pulmonary emphysema.
Duchenne muscular dystrophy (DMD) is the most common lethal genetic disease in children worldwide. Thanks to research underway at the Cedars-Sinai Heart Institute, this calculus may be changing.
Each year approximately 50,000 American women experience pregnancy complications that put mother and baby at risk for serious illness and even death. A Cedars-Sinai study could help determine the risk factors associated with women suffering from the most severe maternal illnesses.
Methicillin-resistant Staphylococcus aureus (MRSA) is an antibiotic-immune superbug that causes some 80,000 infections and 11,000 related deaths per year. Cedars-Sinai investigators suggest the main treatment against staph bacteria — beta-lactam antibiotics — may actually may make patients sicker.